期刊
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
卷 1828, 期 12, 页码 2815-2827出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbamem.2013.04.016
关键词
gamma-Secretase, regulated intramembrane proteolysis; Presenilin; APP; Notch; Alzheimer
资金
- VIB
- KU Leuven [GOA/11/009]
- Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0663.09N, G.0.708.10N, G.A091.11]
- federal government [IAP P7/16]
- Hercules foundation [AKUL/08/058, AKUL/09/037, AKUL/11/30]
- SAO/FRA [12012]
gamma-secretase, which assembles as a tetrameric complex, is an aspartyl protease that proteolytically cleaves substrate proteins within their membrane-spanning domain; a process also known as regulated intramembrane proteolysis (RIP). RIP regulates signaling pathways by abrogating or releasing signaling molecules. Since the discovery, already >15 years ago, of its catalytic component, presenilin, and even much earlier with the identification of amyloid precursor protein as its first substrate, gamma-secretase has been commonly associated with Alzheimer's disease. However, starting with Notch and thereafter a continuously increasing number of novel substrates, gamma-secretase is becoming linked to an equally broader range of biological processes. This review presents an updated overview of the current knowledge on the diverse molecular mechanisms and signaling pathways controlled by gamma-secretase, with a focus on organ development homeostasis and. dysfunction. This article is part of a Special Issue entitled: Intramembrane Proteases. (C) 2013 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据